Synthesis, characterization, and tuberculostatic activity of novel 2-(4-nitrobenzoyl)hydrazinecarbodithioic acid derivatives

Monatshefte fur Chemie

Volumn 143, Issue 4, 2012, Pages 607-617

  Gobis, Katarzyna ^a   Foks, Henryk ^a   Augustynowicz Kopec, Ewa ^b   Napiorkowska, Agnieszka ^b   Szczesio, Malgorzata ^c   Olczak, Andrzej ^c   Glowka, Marek L ^c  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b NATIONAL TUBERCULOSIS AND LUNG DISEASES RESEARCH INSTITUTE   (Poland)

^c LODZ UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

5 (4 Nitrophenyl) 1,3,4 oxadiazole ; Crystal structure; Drug research; Structure activity relationship; Tuberculostatic activity

Indexed keywords

EID: 84859237189     PISSN: 00269247     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00706-011-0708-y     Document Type: Article

References (33)

1. Lawn SD, Zumla AI (2011) Lancet 378:57
2. Dye C, Williams BG (2010) Science 328:856
3. Lönnroth K, Castro KG, Muhwa Chakaya J, Singh Chauhan L, Floyd K, Glaziou P, Raviglione MC (2010) Lancet 375:1814
4. Dheda K, Warren RM, Zumla A, Grobusch MP (2010) Infect Dis Clin N Am 24:705
5. Migliori GB, D'Arcy Richardson M, Sotgiu G, Lange C (2009) Clin Chest Med 30:637
6. Nachega JB, Maartens G (2009) Clinical aspects of tuberculosis in HIV-infected adults. In: Schaaf HS, Zumla AI (eds) Tuberculosis. A comprehensive clinical reference. Saunders-Elsevier, Philadelphia, p 524.531
7. Swaminathan S, Banu Rekha VV (2009) Side Eff Drugs Annu 31:495
8. Janin YL (2007) Bioorg Med Chem 15:2479
9. Abdel-Aziz M, Abdel-Rahman HM (2010) Eur J Med Chem 45:3384
10. Karali N, Gürsoy A, Kandemirli F, Shvets N, Kaynak FB, Özbey S, Kovalishyn V, Dimoglo A (2007) Bioorg Med Chem 15:5888
11. Bedia KK, Elçin O, Seda U, Fatma K, Nathaly S, Serim R, Dimoglo A (2006) Eur J Med Chem 41:1253
12. Glówka ML, Martynowski D, Olczak A, Kozlowski K, Olubek Z, Orlewska C, Foks H (1999) Polish J Chem 73:845
13. Glówka ML, Martynowski D, Olczak A, Orlewska C, Foks H, Bojarska J, Szczesio M, Golka J (2005) J Chem Cryst 35:477
14. Gobis K, Foks H, Zwolska Z, Augustynowicz-Kopeç E, Glówka ML, Olczak A, Sabisz M (2011) Monatsh Chem 142:1137
15. Chen P (1935) J Chin Chem Soc 3:251
16. Northon PP, Sunder S (1977) J Heterocycl Chem 14:1147
17. Danila G, Ungureanu M, Lupascu D (2000) Farmacia (Bucharest) 48:21
18. Nesterova OO, Voevudsky MV (2009) Chem Heterocycl Comp 45:750
19. Gobis K, Foks H, Zuralska A, Kȩdzia A (2006) Heterocycles 68:2615
20. Chau N (1982) J Heterocycl Chem 19:541
21. Gobis K, Foks H, Zwolska Z, Augustynowicz-Kopeć E (2006) Phosphorus. Sulfur Silicon Relat Elem 181:965
22. Muhi-eldeen ZZ, Juma'a G, Al-kaissi E, Nouri L (2008) Jordan J Chem 3:233
23. Nyfeler R, Eckhardt R, Beriger E, Kristiansen O (1988) Preparation of 2-mercapto-5-pyridyl-1,3,4-oxadiazoles and-1,3,4-thiadiazoles as nematocidal agents. Eur Patent 285:565
24. Nyfeler R, Eckhardt R, Beriger E, Kristiansen O (1989) Chem Abstr 110:114837
25. Navarrete-Vázquez G, Molina-Salinas GM, Duarte-Fajardo ZV, Vargas-Villarreal J, Estrada-Soto S, González-Salazar F, Hernández-Núňez E, Said-Fernández S (2007) Bioorg Med Chem 15:5502
26. Yar MS, Siddiqui AA, Ali MA (2007) J Chin Chem Soc 54:5
27. Youmans GP (1947) Am Rev Tuberc 56:376
28. Youmans GP, Youmans AS (1949) J Bacteriol 58:247
29. Atlas RM, Singler JW (1995) Handbook of media for clinical microbiology. CRC Press, Boca Raton, p 313.326
30. Foks H, Buraczewska M, Manowska W, Sawlewicz J (1971) Dissert Pharm Pharmacol 23:49
31. Bruker (2003) SAINT (Version 6.45) and SADABS (Version 2.10), Bruker AXS Inc 5464 East Cheryl Parkway, Medison, WI53711-55373
32. Sheldrick GM (1990) SHELXTL Pcmt Siemens Analytical X-ray Instruments Inc. Madison, Wisconsin
33. Sheldrick GM (1997) SHELXL-97, a FORTRAN-77 program for the refinement of crystal structures from diffraction data, University of Göttingen, Germany